Skip to main content
OpenTrials

Clinical trial condition

Thrombocytosis

Explore clinical trials studying Thrombocytosis. Study availability and eligibility vary by location and protocol.

177 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytosis trial results

Completed

Anagre Cap. in Patients With High-Risk Essential Thrombocythemia

NCT03232177

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • National Health Insurance Service Ilsan Hospital Goyang-si, Gyeonggi-do, South Korea
  • The Catholic University of Korea. ST. Vincents Hospital Suwon, Gyeonggi-do, South Korea
  • Hallym UNIV. Medical Center Anyang, South Korea
  • Daegu Catholic University Medical Center Daegu, South Korea
View all 21 locations
View Trial Details
Completed

French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia

NCT01192347

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • GH Pitie Salpetriere Paris, Cedex 13, France
  • CH DU Pays D Aix Aix-en-Provence, Cedex 1, France
  • Hopital Dupuytren Limoges, Cedex 1, France
  • Hopital Emile Muller Mulhouse, Cedex 1, France
View all 46 locations
View Trial Details
Completed

Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia

NCT01214915

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Akita University Hospital Akita, Japan
  • Juntendo University Hospital Hongo 3-1-3, Bunkyo-ku, Japan
  • Tokyo Metropolitan Cancer and Infectious diseases Center Kom Honkomagome 3-18-22, Bunkyo-ku, Japan
  • Nippon Medical School Hospital Sendagi 1-1-5, Bunkyo-ku, Japan
View all 19 locations
View Trial Details
Completed

Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia

NCT01467661

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Akita University Hospital Akita, Japan
  • Tokyo Metropolitan Cancer and Infectious diseases Center Kom Honkomagome 3-18-22, Bunkyo-ku, Japan
  • Nippon Medical School Hospital Sendagi 1-1-5, Bunkyo-ku, Japan
  • Chiba University Hospital Chuo-ku Inohana 1-8-1, Chiba-shi, Japan
View all 16 locations
View Trial Details
Completed

Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments

NCT00567502

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +6 more
Locations
  • Clinic of Haematology Limassol, Cyprus
  • Rigshospitalet Copenhagen, Denmark
  • SUS-Esbjerg Maematologisk afdelning Esbjerg, Denmark
  • Herlev Hospital Herlev, Denmark
View all 164 locations
View Trial Details
Completed

A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients

NCT00202644

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • University Multiprofile Hospital for Active Treatment ''Dr Georgi Stranski'' - Pleven Pleven, Bulgaria
  • University Multiprofile Hospital for active Treatment ''Alexandrovska'' Clinic of Haematology Sofia, Bulgaria
  • University Multiprofile Hospital for Active Treament ''Sv. Marina'' - Varna Haematology Clinic Varna, Bulgaria
  • CHU Angers Services des Maladies du Sang Angers, Cedex 09, France
View all 15 locations
View Trial Details
Completed

Pediatric Disease Registry in Essential Thrombocythaemia (ET)

NCT01198717

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Paediatric Clinic University Hospital Olomouc Olomouc, Czechia
  • Clinic of Paediatric haematology and oncology University Hospital Motol Prague, Czechia
  • Paediatric Oncology Unit, Hopital Cote De Nacre Caen, France
  • Practicen Hospitalier , Institute d'Hematologie et Oncologie Pediatrique Lyon, France
View all 32 locations
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details

Related conditions